SAG
BMRN icon

SageView Advisory Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

SageView Advisory Group’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,945
Closed -$264K – 542
2023
Q4 		$264K Buy
+2,945
New +$264K 0.01% 548